aptaTargets awarded with Programa Cheque Innovación 2024 from the Community of Madrid
23 December, 2024
aptaTargets awarded with the Programa Cheque Innovación 2024 from the Community of Madrid to develop a new Phase 1a clinical trial APTABOLUS.
We use our own and third-party cookies to improve our services and show commercials related to your own preferences through the analysis of your browsing habits. Clicking Accept entails your acceptance in using them.
You can change this configuration or obtain additional information on legal warning.ACCEPT